The estimated Net Worth of Scott Durbin is at least $2.98 Millón dollars as of 23 August 2017. Mr. Durbin owns over 5,000 units of Viveve Medical Inc stock worth over $5 and over the last 8 years he sold VIVE stock worth over $0. In addition, he makes $2,983,570 as Chief Executive Officer y Director at Viveve Medical Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Durbin VIVE stock SEC Form 4 insiders trading
Scott has made over 3 trades of the Viveve Medical Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVE stock worth $26,250 on 23 August 2017.
The largest trade he's ever made was buying 5,000 units of Viveve Medical Inc stock on 23 August 2017 worth over $26,250. On average, Scott trades about 471 units every 25 days since 2016. As of 23 August 2017 he still owns at least 11,568 units of Viveve Medical Inc stock.
You can see the complete history of Mr. Durbin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Scott Durbin biography
Scott C. Durbin serves as Chief Executive Officer, Director of the Company. Mr. Durbin joined Viveve, Inc. as its Chief Financial Officer in February 2013 and was appointed as the Chief Financial Officer and Secretary of Viveve Medical, Inc. on September 23, 2014. From June 2012 to January 2013, he served as an advisor and Acting Chief Financial Officer for Viveve, Inc. Prior to joining Viveve, Inc., from June 2010 to October 2011, he was Chief Financial Officer of Aastrom Biosciences (“Aastrom”), a publicly traded, cardiovascular cell therapy company. Before Aastrom, he spent six years as Chief Operating and Financial Officer for Prescient Medical (“Prescient”) from May 2004 to June 2010, a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks. Prior to Prescient, from January 2003 to April 2004, he spent several years as a financial consultant for two publicly traded biotech companies, Scios Inc., a Johnson & Johnson company, and Alteon Inc. Mr. Durbin began his career in corporate finance as an investment banker in the Healthcare and M&A groups at Lehman Brothers Inc. from August 1999 to January 2003, where he focused on mergers and acquisitions and financings for the life science industry. At Lehman, he successfully executed over $5 billion in transactions for medical device and biotechnology companies. He began his career as a Director of Neurophysiology for Biotronic, Inc. Mr. Durbin received a B.S. from the University of Michigan and an M.P.H. in Health Management with Honors from the Yale University School of Medicine and School of Management.
What is the salary of Scott Durbin?
As the Chief Executive Officer y Director of Viveve Medical Inc, the total compensation of Scott Durbin at Viveve Medical Inc is $2,983,570. There are no executives at Viveve Medical Inc getting paid more.
How old is Scott Durbin?
Scott Durbin is 51, he's been the Chief Executive Officer y Director of Viveve Medical Inc since 2018. There are 9 older and 1 younger executives at Viveve Medical Inc. The oldest executive at Viveve Medical Inc is Arlene Morris, 68, who is the Independent Director.
What's Scott Durbin's mailing address?
Scott's mailing address filed with the SEC is 345 Inverness Dr S #250, Englewood, CO 80112, USA.
Insiders trading at Viveve Medical Inc
Over the last 8 years, insiders at Viveve Medical Inc have traded over $444,564 worth of Viveve Medical Inc stock and bought 3,021,700 units worth $13,021,042 . The most active insiders traders include Sachs Group Incgoldman Sach..., Daniel Janney y Capital Management, Llcston.... On average, Viveve Medical Inc executives and independent directors trade stock every 80 days with the average trade being worth of $83. The most recent stock trade was executed by Sachs Group Incgoldman Sach... on 30 September 2019, trading 92,425 units of VIVE stock currently worth $444,564.
What does Viveve Medical Inc do?
viveve provides women low risk, high reward medical procedures that promote personal health and wellness. the company is committed to innovative technological advances and to broad and elucidating education for medical and lay audiences worldwide.
What does Viveve Medical Inc's logo look like?
Complete history of Mr. Durbin stock trades at Viveve Medical Inc y Motus GI Inc
Viveve Medical Inc executives and stock owners
Viveve Medical Inc executives and other stock owners filed with the SEC include:
-
Scott Durbin,
Chief Executive Officer, Director -
Sean Shapiro,
Vice President - U.S. Sales -
Scott C. Durbin,
CEO & Director -
Jim Robbins,
Principal Financial Officer and Administration, Principal Accounting and Financial Officer -
Jim B. Robbins,
Sr. VP of Fin. & Admin. and Principal Accounting & Financial Officer -
Deborah Ann Jorn M.B.A.,
Sr. Advisor to the CEO & Director -
Debora Ann Jorn M.B.A.,
Sr. Advisor to the CEO & Director -
Sharon Presnell,
Independent Director -
Arlene Morris,
Independent Director -
Debora Jorn,
Director -
Steven Basta,
Independent chairman of the Board -
Suzon D. Lommel,
Sr. VP of Regulatory & Quality Affairs -
Lori McMillan,
VP of HR -
Gary Kaiser,
VP of Global Marketing -
Jeff Sinclair,
VP of International Sales -
Jeannie Swindle,
Sr. Director of Corp. Communications -
Martin Kerber P.E.,
VP of Research, Devel. & Operations -
Daniel Janney,
Director -
Patricia Scheller,
Chief Executive Officer -
Lori H Bush,
Director -
Brigitte Smith,
Director -
Jon M Plexico,
Director -
Capital Management, Llcston...,
Director -
Karen L. Zaderej,
Director -
James G. Atkinson,
CBO & President -
Sachs Group Incgoldman Sach...,